TREATMENT WITH A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST LIRAGLUTIDE DECREASES ALBUMINURIA IN OVERWEIGHT TYPE 2 DIABETIC PATIENTS

被引：0
|
作者：
Bulum, Tomislav [1 ]
Blaslov, Kristina [1 ]
Prkacin, Ingrid [2 ]
Zibar, Karin [1 ]
Duvnjak, Lea [1 ]
机构：
[1] Univ Zagreb, Sch Med, Univ Hosp Merkur, Vuk Vrhovac Clin Diabet Endocrinol & Metab Dis, Zagreb 41001, Croatia
[2] Univ Zagreb, Sch Med, Univ Hosp Merkur, Dept Internal Med, Zagreb 41001, Croatia
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2015年 / 30卷
关键词：
D O I：
10.1093/ndt/gfv195.18
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP474
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TREATMENT WITH A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE DECREASES ALBUMINURIA IN OVERWEIGHT TYPE 2 DIABETIC PATIENTS
    Bulum, Tomislav
    Prkacin, Ingrid
    Duvnjak, Lea
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 1487 - 1487
  • [2] Glucagon-like peptide-1 receptor agonists decreases albuminuria in overweight patients with type 2 diabetes
    Bulum, T.
    Blaslov, K.
    Tomic, M.
    Duvnjak, L.
    DIABETOLOGIA, 2015, 58 : S532 - S533
  • [3] TREATMENT WITH A GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST EXENATIDE DECREASES SYSTOLIC BLOOD PRESSURE IN OVERWEIGHT TYPE 2 DIABETIC PATIENTS
    Bulum, T.
    Blaslov, K.
    Prkacin, I.
    Zibar, K.
    Duvnjak, L.
    JOURNAL OF HYPERTENSION, 2015, 33 : E300 - E300
  • [4] EFFECTS OF GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST LIRAGLUTIDE ON BLOOD PRESSURE AND HEART RATE IN OVERWEIGHT TYPE 2 DIABETIC PATIENTS
    Bulum, T.
    Blaslov, K.
    Prkacin, I.
    Zibar, K.
    Duvnjak, L.
    JOURNAL OF HYPERTENSION, 2015, 33 : E299 - E300
  • [5] The Glucagon-Like Peptide-1 Receptor Agonist, Liraglutide, Attenuates the Progression of Overt Diabetic Nephropathy in Type 2 Diabetic Patients
    Imamura, Shigeki
    Hirai, Keiji
    Hirai, Aizan
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2013, 231 (01): : 57 - 61
  • [6] Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
    A. Faurschou
    F. K. Knop
    J. P. Thyssen
    C. Zachariae
    L. Skov
    T. Vilsbøll
    Acta Diabetologica, 2014, 51 : 147 - 150
  • [7] Improvement in psoriasis after treatment with the glucagon-like peptide-1 receptor agonist liraglutide
    Faurschou, A.
    Knop, F. K.
    Thyssen, J. P.
    Zachariae, C.
    Skov, L.
    Vilsboll, T.
    ACTA DIABETOLOGICA, 2014, 51 (01) : 147 - 150
  • [8] The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide
    Jennings, L.
    Nestor, L.
    Molloy, O.
    Hughes, R.
    Moriarty, B.
    Kirby, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (03) : 858 - 859
  • [9] Sleep is increased by liraglutide, a glucagon-like peptide-1 receptor agonist, in rats
    Fang, Jidong
    Miller, Patti
    Grigson, Patricia S.
    BRAIN RESEARCH BULLETIN, 2023, 192 : 142 - 155
  • [10] Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
    Sawada, Noritaka
    Adachi, Kei
    Nakamura, Nobuhisa
    Miyabe, Megumi
    Ito, Mizuho
    Kobayashi, Shuichiro
    Miyajima, Shin-ichi
    Suzuki, Yuki
    Kikuchi, Takeshi
    Mizutani, Makoto
    Toriumi, Taku
    Honda, Masaki
    Mitani, Akio
    Matsubara, Tatsuaki
    Naruse, Keiko
    JOURNAL OF DIABETES RESEARCH, 2020, 2020
12345